Amino acid replacement: P483L.
C1198602T
P476L | Aplip1-PA; P483L | Aplip1-PB
P483L
Site of nucleic acid difference inferred by FlyBase based on reported amino acid change.
paralytic | larval stage | posterior (with Df(3L)Fpa2)
Aplip1EK4/Df(3L)Fpa2 larvae show defects in axonal transport, resulting in accumulations of protein in nerves. Maximum bouton diameter at the neuromuscular junction is normal in these larvae.
Aplip1EK4 larvae show posterior paralysis and axonal swelling. This phenotype is enhanced in Aplip1EK4/Df(3L)Fpa2 larvae. While the anterograde and retrograde flux of vesicles are reduced by ~35% in Aplip1EK4 mutant axons, only the retrograde flux of mitochondria is reduced (by 60%) and anterograde mitochondrial flux is unaffected.
Homozygous or hemizygous Aplip1EK4 mutants have organelle jams and show a "flipper" phenotype (partial paralysis of larvae).
Aplip1EK4 has paralytic | posterior | larval stage phenotype, suppressible by Klp64Dk5
Aplip1EK4 has paralytic | posterior | larval stage phenotype, suppressible by Dhc64Cek1
Aplip1EK4, Khc16/Khc[+] has paralytic | dominant | larval stage phenotype
Aplip1EK4/Aplip1[+], Khc16 has paralytic | dominant | larval stage phenotype
Aplip1EK4/+; Khc27/+ larvae show posterior paralysis in 86% of cases; these mutants also show axonal swelling. Expression of the Aplip1+tHa transgene fully rescues the posterior paralysis phenotype of Aplip1EK4/+; Khc27/+ larvae and partially rescues the axonal swelling phenotype. Df(3L)34ex5, Aplip1EK4 larvae show slightly lower levels of posterior paralysis and similar levels of axonal swelling to Aplip1EK4 flies. Dhc64Cek1, Aplip1EK4 larvae show lower levels of posterior paralysis and axonal swelling than Aplip1EK4 larvae. In Aplip1EK4, Klp64Dk5 double mutants the posterior paralysis and axonal swelling of Aplip1EK4 single mutants are completely suppressed.